Market Overview

Morning Market Gainers

Share:

ZS Pharma Inc (NASDAQ: ZSPH) shares jumped 40.69 percent to $89.07 after the company agreed to be acquired by AstraZeneca plc (ADR) (NYSE: AZN) for $2.7 billion.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares surged 34.06 percent to $14.13. Lexicon Pharma reported a Q3 loss of $0.34 per share. Sanofi SA (ADR) (NYSE: SNY) and Lexicon agreed to collaborate on Sotagliflozin, a potential diabetes treatment.

TrueCar Inc (NASDAQ: TRUE) rose 31.65 percent to $8.07 after the company reported upbeat Q3 results.

Stamps.com Inc. (NASDAQ: STMP) shares climbed 25.51 percent to $95.36 on stronger-than-expected Q3 results.

Builders FirstSource, Inc. (NASDAQ: BLDR) shares rose 23.40 percent to $15.19 after the company reported upbeat Q3 earnings.

Weight Watchers International, Inc. (NYSE: WTW) shares jumped 23.57 percent to $20.92 after the company reported upbeat Q3 results and raised its FY15 earnings forecast.

Tableau Software Inc (NYSE: DATA) shares surged 20.19 percent to $101.43 on better-than-expected quarterly earnings.

Horizon Pharma PLC (NASDAQ: HZNP) shares gained 16.86 percent to $20.17 after the company reported better-than-expected Q3 results and raised its FY15 forecast.

Youku Tudou Inc (ADR) (NYSE: YOKU) shares gained 9.07 percent to $26.58 after the company agreed to be acquired by Alibaba Group Holding Ltd (NYSE: BABA) for $27.60 per ADS share in cash.

NVIDIA Corporation (NASDAQ: NVDA) shares rose 8.88 percent to $30.17 after the company reported upbeat results for the third quarter.

Relypsa Inc (NASDAQ: RLYP) shares surged 5.33 percent to $19.75. Relypsa reported a Q3 loss of $1.24 per share and announced new employment inducement grants. Guggenheim Securities initiated coverage on Relypsa with a Buy rating and a $46.00 price target.

Cellectis SA (ADR) (NASDAQ: CLLS) shares jumped 5.23 percent to $43.44 after surging 17.91 percent on Thursday.

Posted-In: Market GainersNews Intraday Update Markets Movers

 

Related Articles (AZN + BABA)

View Comments and Join the Discussion!

1 Big Concern For TripAdvisor

Benzinga's Top Downgrades